These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28417640)

  • 1. Combinations of L-N
    Smee DF; Dagley A; Tarbet EB
    Antivir Chem Chemother; 2017 Apr; 25(1):11-17. PubMed ID: 28417640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses.
    Smee DF; Wong MH; Bailey KW; Sidwell RW
    Antivir Chem Chemother; 2006; 17(4):185-92. PubMed ID: 17066897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.
    Smee DF; Hurst BL; Wong MH; Tarbet EB; Babu YS; Klumpp K; Morrey JD
    Antiviral Res; 2010 Oct; 88(1):38-44. PubMed ID: 20633577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents.
    Smee DF; Julander JG; Tarbet EB; Gross M; Nguyen J
    Antiviral Res; 2012 Oct; 96(1):13-20. PubMed ID: 22809862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus.
    Tarbet EB; Vollmer AH; Hurst BL; Barnard DL; Furuta Y; Smee DF
    Arch Virol; 2014 Jun; 159(6):1279-91. PubMed ID: 24311151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice.
    Smee DF; Hurst BL; Wong MH; Bailey KW; Tarbet EB; Morrey JD; Furuta Y
    Antimicrob Agents Chemother; 2010 Jan; 54(1):126-33. PubMed ID: 19901093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosol administration increases the efficacy of oseltamivir for the treatment of mice infected with influenza viruses.
    Leyva-Grado VH; Palese P
    Antiviral Res; 2017 Jun; 142():12-15. PubMed ID: 28286235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
    Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
    Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of oseltamivir with azithromycin does not show additional benefits over oseltamivir monotherapy in mice infected with influenza A(H1N1)pdm2009 virus.
    Fage C; Pizzorno A; Rhéaume C; Abed Y; Boivin G
    J Med Virol; 2017 Dec; 89(12):2239-2243. PubMed ID: 28792077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of TheraMax on influenza virus infections in cell culture and in mice.
    Smee DF; Hurst BL; Wong MH
    Antivir Chem Chemother; 2011 Jul; 21(6):231-7. PubMed ID: 21730370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice.
    Bantia S; Kellogg D; Parker C; Upshaw R; Ilyushina NA; Babu YS
    Antiviral Res; 2011 Apr; 90(1):17-21. PubMed ID: 21316393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infection.
    Garozzo A; Tempera G; Ungheri D; Timpanaro R; Castro A
    Int J Immunopathol Pharmacol; 2007; 20(2):349-54. PubMed ID: 17624247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
    Tanaka A; Nakamura S; Seki M; Iwanaga N; Kajihara T; Kitano M; Homma T; Kurihara S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
    Antivir Ther; 2015; 20(1):11-9. PubMed ID: 24517996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice.
    Smee DF; Hurst BL; Wong MH; Bailey KW; Morrey JD
    Antimicrob Agents Chemother; 2009 May; 53(5):2120-8. PubMed ID: 19273672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in mice.
    Smee DF; Barnard DL; Jones SM
    Antiviral Res; 2016 Dec; 136():45-50. PubMed ID: 27771390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-viral activity of a complex of the glycyrrhizic acid-alpha-glutamyltryptophan against the experimental lethal influenza infection in white mice caused by the oseltamivir-resistant strain of the virus].
    Smirnov VS; Garshinina AV; Shtro AA; Anikin VB; Galochkina AV; Beliavskaia SV; Zarubaev VV
    Vopr Virusol; 2014; 59(5):31-8. PubMed ID: 25895209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Influenza Virus Entry Inhibitor Targets Class II PI3 Kinase and Synergizes with Oseltamivir.
    O'Hanlon R; Leyva-Grado VH; Sourisseau M; Evans MJ; Shaw ML
    ACS Infect Dis; 2019 Oct; 5(10):1779-1793. PubMed ID: 31448902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
    Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
    Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rimantadine and oseltamivir demonstrate synergistic combination effect in an experimental infection with type A (H3N2) influenza virus in mice.
    Galabov AS; Simeonova L; Gegova G
    Antivir Chem Chemother; 2006; 17(5):251-8. PubMed ID: 17176629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.
    Kitano M; Kodama M; Itoh Y; Kanazu T; Kobayashi M; Yoshida R; Sato A
    Antimicrob Agents Chemother; 2013 May; 57(5):2286-94. PubMed ID: 23478960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.